Celldex Therapeutics CLDX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$5.31M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 44.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 9.64% to 12.65% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +4,914,623 | 11.0% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +556,724 | 1.3% |
| Silverarc Capital Management, LLC | Hedge Fund | 2026/Q3 | +487,589 | 0.6% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +447,280 | 1.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +398,788 | 0.8% |
| Fisher Investments | Mutual Fund | 2026/Q3 | +261,178 | 1.6% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +383,874 | 0.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +2,599,855 | 6.0% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +1,655,172 | 3.7% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +1,650,000 | 2.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,632,645 | 8.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,096,259 | 5.0% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +989,442 | 1.3% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +983,195 | 12.2% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +642,171 | 1.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 24 Jun 2026 | Harry Penner | Chairperson | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Herbert Conrad | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | James Marino | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Ronald Pepin | Chief Business Officer & Senior VP | Other Derivative Acquisition | +20,000 | $34.09 | 20,000 |
| 24 Jun 2026 | Anthony Marucci | Chief Executive Officer | Other Derivative Acquisition | +375,000 | $34.09 | 375,000 |
| 24 Jun 2026 | Tibor Keler | Founder, Chief Scientific Officer & Executive VP | Other Derivative Acquisition | +115,000 | $34.09 | 115,000 |
| 24 Jun 2026 | Diane Young | Senior VP & Chief Medical Officer | Other Derivative Acquisition | +57,000 | $34.09 | 57,000 |
| 24 Jun 2026 | Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration | Other Derivative Acquisition | +95,000 | $34.09 | 95,000 |
| 24 Jun 2026 | Garry Neil | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Keith Brownlie | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Cheryl Cohen | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Elizabeth Crowley | Chief Product Development Officer & Senior VP | Other Derivative Acquisition | +100,000 | $34.09 | 100,000 |
| 24 Jun 2026 | Rita Jain | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Sam Martin | Senior VP, CFO, Secretary & Treasurer | Other Derivative Acquisition | +93,000 | $34.09 | 93,000 |
| 24 Jun 2026 | Margo Heath-Chiozzi | Senior Vice President of Regulatory Affairs | Other Derivative Acquisition | +95,000 | $34.09 | 95,000 |
| 24 Jun 2026 | Denice Torres | Independent Director | Other Derivative Acquisition | +26,000 | $34.09 | 26,000 |
| 24 Jun 2026 | Freddy Jimenez | General Counsel | Other Derivative Acquisition | +93,000 | $34.09 | 93,000 |
| 24 Jun 2026 | Teri Lawver | SVP & Chief Commercial Officer | Other Derivative Acquisition | +90,000 | $34.09 | 90,000 |
| 1 Jan 2026 | Sam Martin | Senior VP, CFO, Secretary & Treasurer | Derivative Exercise and Retained | +4,817 | $10.38 | 32,942 |
| 14 Dec 2025 | Ronald Pepin | Chief Business Officer & Senior VP | Derivative Exercise and Retained | +19,333 | $9.02 | 20,097 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,936,646 | 12.7% | 10.4 |
| 15 Oct 2026 | 9,598,891 | 12.2% | 5.9 |
| 30 Sep 2026 | 11,006,720 | 14.0% | 3.8 |
| 15 Sep 2026 | 8,953,127 | 11.4% | 13.1 |
| 31 Aug 2026 | 8,641,597 | 11.0% | 12.2 |
| 14 Aug 2026 | 7,569,702 | 9.6% | 7.9 |
No comments yet — be the first to weigh in on CLDX.
Sign in to join the discussion.